A WOMAN’S PLACE LAUNCHES NEW PODCAST EPISODE for A NEW TECHNOLOGY FOR FIBROIDS
Dr. Holly Miller is Board Certified by the American Board of Obstetrics and Gynecology. She is a Fellow of the American College of Obstetrics and Gynecology, a member of the American Medical Association (AMA), and the Collier County Medical Society (CCMS)
The episode focuses on new technologies available for the treatment of fibroids. Dr. Miller is a nationally recognized expert in women's health and minimally invasive surgery including the Acessa ProVu® system, a safe and effective minimally invasive alternative for women with symptomatic fibroids who would otherwise require a hysterectomy, laparoscopic myomectomy, or uterine fibroid embolization. The medical term for the Acessa procedure is Laparoscopic Radiofrequency Ablation (Lap RFA).
Dr Miller brought the Acessa procedure to southwest Florida in the fall of 2021, allowing women to more choices for fibroid treatment. The Acessa procedure allows for a thorough and minimally invasive method of treating your fibroids. It was designed to preserve healthy uterine tissue by focusing treatment only on the fibroid (versus cutting into the uterus or removing it completely) while relieving symptoms caused by fibroids.
Maggie MacKay, hostess of Top Docs says, “Fibroids are nothing to ignore. This has been so fascinating and informative and hopeful, especially comparing it to several years ago and how far treatment options have come..” To listen to the episode on the Top Docs Podcast and Show, check out Top Docs on Apple Podcasts, Spotify, Google Podcasts, Pandora, or I Heart Radio, or visit https://www.topdocsshow.com/.
About Dr. Holly Miller and A Woman’s Place: Dr. Holly Miller is Board Certified by the American Board of Obstetrics and Gynecology. She is a Fellow of the American College of Obstetrics and Gynecology, a member of the American Medical Association (AMA), and the Collier County Medical Society (CCMS).
https://www.awpnaples.com/
Dr. Holly Miller
A Woman's Place Naples
+1 239-513-0053
email us here
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
